Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • PEREGRINE PHARMACEUTICALS IN Income Statement

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2009 FY2008 FY2007 FY2006 FY2005
    Net Sales/Revenues 18.15 M 6.09 M 3.71 M 3.19 M 4.96 M
    Cost of Goods Sold (Excluding Depreciation)
    Depreciation, Depletion and Amortization
    Gross Income 9.09 M 1.29 M 412,000.00 -104,000.00 558,000.00
    Selling, General & Admin Expenses
    Other Operating Expense
    Operating Expenses - Total
    Operating Income -16.32 M -24.14 M -21.91 M -19.08 M -15.70 M
    Extraordinary Credit - Pretax
    Extraordinary Charge - Pretax
    Non-operating Interest Income
    Reserves Inc (Dec)
    Pretax Equity in Earnings
    Other Income/Expenses - Net
    Earnings Before Interest & Taxes (EBIT)
    Interest Expenses On Debt
    Interest Capitalized
    Pretax Income
    Income Taxes
    Current Domestic Income Tax
    Current Foreign Income Tax
    Deferred Domestic Income Tax
    Deferred Foreign Income Tax
    Income Tax Credits
    Minority Interest
    Equity in Earnings
    After Tax Income Expense
    Discontinued Operations
    Net Income Before Extra Items/Preferred Div
    Extra Items & Gain (Loss) Sale of Assets
    Net Income Before Preferred Dividends -16.52 M -23.18 M -20.80 M -17.06 M -15.45 M
    Preferred Dividend Requirements
    Net Income Available to Common